Jeffrey Alan Wolf - 14 Dec 2023 Form 4 Insider Report for Theriva Biologics, Inc. (TOVX)

Role
Director
Signature
/s/ Jeffrey Wolf
Issuer symbol
TOVX
Transactions as of
14 Dec 2023
Net transactions value
$0
Form type
4
Filing time
15 Dec 2023, 16:01:42 UTC
Previous filing
16 Dec 2022
Next filing
17 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TOVX Stock Options (right to buy) Award $0 +110,000 $0.000000 110,000 14 Dec 2023 Common Stock 110,000 $0.5875 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest pro rata on a monthly basis over 12 months.